SVG Sprites

Press

LDPN in the News 01.19.2022

Sen. Wyden Continues Investigation Into Big Pharma Tax Practices

Not only have Big Pharma corporations raised the prices of more than 450 drugs already this year, but this investigation from Senate Finance shows how they’re using complex loopholes to avoid paying taxes on the sales of those drugs.

LDPN in the News 11.16.2021

Rx companies continue price gouging Americans

It is absolutely ridiculous that at the same time Big Pharma is spending literally hundreds of millions of dollars to try and stop lawmakers from lowering prescription drug prices for families, they’re also raising prices of the most expensive drugs in the U.S. to inflate profits.

LDPN in the News 10.07.2021

Statesman Journal: The problem with Rep. Schrader’s shifting priorities on lowering drug prices

Congress is debating legislation right now that would lower drug prices, cap out-of-pocket costs and save American taxpayers hundreds of billions of dollars over the next decade.

LDPN in the News 08.02.2021

WCTV: Florida Alliance for Retired Americans pushes for lower prescription drug prices

The Florida Alliance for Retired Americans celebrated the 56th birthday of Medicare and Medicaid on Friday; the group is calling on Congress to lower prescription drug prices.

LDPN in the News 07.23.2021

Times News Online: Legislators – U.S. Rep. Susan Wild

Wild has sent a letter to Democratic leadership urging them to include Medicare negotiation power in the upcoming reconciliation bill.

LDPN in the News 07.21.2021

Up North News: Drug Costs Are Skyrocketing. Congress Must Step In.

A Green Bay resident writes in support of HR3, a Democratic bill that would enact several measures to lower drug costs.

LDPN in the News 07.19.2021

Fierce Pharma: Pharma Congress has a ‘time-limited window’ to shake up drug pricing, employers, health groups say

A chance for meaningful drug pricing reform is upon us, dozens of purchasers, healthcare and employer groups contend. But Congress needs to capitalize on its “time-limited” opportunity, or the problem could stagnate or worsen.

Thank You for standing with us to put people before Pharma Profits!

Join our campaign, endorse our principles